Martin Zamora
- Hypoxia-mediated alterations in adenosine receptor expression in rat lungBy Jonas Salys, Adelheid Kratzer, Martin Zamora and Laima Taraseviciene-StewartJonas SalysMedicine, University of Colorado Denver, Aurora, United StatesAdelheid KratzerMedicine, University of Colorado Denver, Aurora, United StatesMartin ZamoraMedicine, University of Colorado Denver, Aurora, United StatesLaima Taraseviciene-StewartMedicine, University of Colorado Denver, Aurora, United States
- The nuclear liver X receptor and its role in smoke exposed rat lungsBy Adelheid Kratzer, Jonas Salys, Martin Zamora and Laima Taraseviciene-StewartAdelheid KratzerMedicine, Pulmonary Sciences and Critical Care Medicine, Denver, CO, United StatesJonas SalysMedicine, Pulmonary Sciences and Critical Care Medicine, Denver, CO, United StatesMartin ZamoraMedicine, Pulmonary Sciences and Critical Care Medicine, Denver, CO, United StatesLaima Taraseviciene-StewartMedicine, Pulmonary Sciences and Critical Care Medicine, Denver, CO, United States
- CD146 in the pathogenesis of COPDBy Adelheid Kratzer, Jonas Salys, Hong Wei Chu, Martin Zamora and Laima Taraseviciene-StewartAdelheid Kratzer1Medicine, University of Colorado Denver, Denver, United StatesJonas Salys1Medicine, University of Colorado Denver, Denver, United StatesHong Wei Chu2Medicine, National Jewish Health, Denver, United StatesMartin Zamora1Medicine, University of Colorado Denver, Denver, United StatesLaima Taraseviciene-Stewart1Medicine, University of Colorado Denver, Denver, United States
- Second hand smoke exposure impairs CD39 expression and function in the lungBy Adelheid Kratzer, Jonas Salys, Jean Sévigny, Martin Zamora and Laima Taraseviciene-StewartAdelheid Kratzer1Medicine, University of Colorado, Aurora, CO, United StatesJonas Salys1Medicine, University of Colorado, Aurora, CO, United StatesJean Sévigny2Microbiology, Infectious Diseases and Immunology, University of Quebec, QC, CanadaMartin Zamora1Medicine, University of Colorado, Aurora, CO, United StatesLaima Taraseviciene-Stewart1Medicine, University of Colorado, Aurora, CO, United States
- Results of a phase 2b multi-center trial of ALN-RSV01 in respiratory syncytial virus (RSV)-infected lung transplant patientsBy Amy Simon, Verena Karsten, Jeff Cehelsky, Shaily Shah, Jared Gollob, Rachel Meyers, Akshay Vaishnaw, Allan Glanville, Martin Zamora, John DeVincenzo, Selim Arcasoy, Michael Musk, Urte Sommerwerk and Jens GottliebAmy Simon1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesVerena Karsten1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesJeff Cehelsky1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesShaily Shah1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesJared Gollob1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesRachel Meyers1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesAkshay Vaishnaw1Research and Development, Alnylam Pharmaceuticals, Cambridge, MA, United StatesAllan Glanville2Thoracic Medicine, St. Vincent's Hospital, Darlinghurst, AustraliaMartin Zamora3Pulmonary and Critical Care, University of Colorado Hospital, Denver, United StatesJohn DeVincenzo4Pediatrics and Infectious Disease, University of Tennessee Health Science Center, Memphis, United StatesSelim Arcasoy5Pulmonary, Columbia University Medical Center, New York, United StatesMichael Musk6Respiratory Disease, Royal Perth Hospital, Wembley, AustraliaUrte Sommerwerk7Respiratory Medicine, Westdeutsches Lungenzentrum am Universitaetsklinikum, Essen, GermanyJens Gottlieb8Respiratory Medicine, Medizinische Hochschule, Hannover, Germany
- Results of a phase 2b multi-center, randomized, double-blind, placebo-controlled study of an RNAi therapeutic, ALN-RSV01, in respiratory syncytial virus (RSV)-infected lung transplant patientsBy Amy Simon, Allan Glanville, Martin Zamora, Tony Hodges, Selim Arcasoy, MIchael Musk, Urte Sommerwerck, John DeVincenzo, Verena Karsten, Shaily Shah, Jeffrey Cehelsky, Sara Nochur, Jared Gollob, Akshay Vaishnaw and Jens GottliebAmy Simon1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesAllan Glanville2Lung Transplant Unit, St. Vincent's Hospital, Darlinghurst, NSW, AustraliaMartin Zamora3Department of Medicine, University of Colorado at Denver Health Sciences Center, Aurora, CO, United StatesTony Hodges4Heart and Lung Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United StatesSelim Arcasoy5Department of Medicine, Columbia University, New York, NY, United StatesMIchael Musk6Advanced Disease Lung Clinic, Royal Perth Hospital, Perth, WA, AustraliaUrte Sommerwerck7Ruhrlandklinik, Universitatsklinikum Essen, GmbH, GermanyJohn DeVincenzo8Department of Pediatrics and Molecular Sciences, University of Tennessee Center for Health Sciences, Memphis, TN, United StatesVerena Karsten1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesShaily Shah1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesJeffrey Cehelsky1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesSara Nochur1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesJared Gollob1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesAkshay Vaishnaw1Clinical Research, Alnylam Pharmaceuticals, Cambridge, MA, United StatesJens Gottlieb9Innere Medizin, Medizinische Hochschule Hannover, Hannover, Germany
- Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH)By Laima Taraseviciene-Stewart, Maike Leberl, Zakaria Moumen, Rajendra Kadam, Uday Kompella, Martin Zamora and Adelheid KratzerLaima Taraseviciene-Stewart1Medicine, University of Colorado, Aurora, CO, United StatesMaike Leberl1Medicine, University of Colorado, Aurora, CO, United StatesZakaria Moumen1Medicine, University of Colorado, Aurora, CO, United StatesRajendra Kadam2School of Pharmacy, University of Colorado, Aurora, CO, United StatesUday Kompella2School of Pharmacy, University of Colorado, Aurora, CO, United StatesMartin Zamora1Medicine, University of Colorado, Aurora, CO, United StatesAdelheid Kratzer1Medicine, University of Colorado, Aurora, CO, United States
- Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH)By Maike Leberl, Ridong Chen, Zakaria Moumen, Martin Zamora and Laima Taraseviciene-StewartMaike Leberl1Medicine, University of Colorado, Aurora, CO, United StatesRidong Chen2Drug Development, APT-Therapeutics, St. Louis, MO, United StatesZakaria Moumen1Medicine, University of Colorado, Aurora, CO, United StatesMartin Zamora1Medicine, University of Colorado, Aurora, CO, United StatesLaima Taraseviciene-Stewart1Medicine, University of Colorado, Aurora, CO, United States
- An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndromeBy Keith C. Meyer, Ganesh Raghu, Geert M. Verleden, Paul A. Corris, Paul Aurora, Kevin C. Wilson, Jan Brozek, Allan R. Glanville and the ISHLT/ATS/ERS BOS Task Force CommitteeKeith C. Meyer2School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USAGanesh Raghu2School of Medicine, University of Washington, Seattle, WA, USAGeert M. Verleden3University of Leuven, Leuven, BelgiumPaul A. Corris4Freeman Hospital, Newcastle upon Tyne, UKPaul Aurora5Great Ormond Street Hospital for Children, London, UKKevin C. Wilson6Boston University Medical Center, Boston, MA, USAJan Brozek7McMaster University, Hamilton, ON, CanadaAllan R. Glanville8The Lung Transplant Unit, St Vincents Hospital, Sydney, Australia9A full list of the ISHLT/ATS/ERS BOS Task Force Committee members and their affiliations can be found in the Acknowledgements section
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.